Phase 1 Lymfactin® Study: 24-month Efficacy and Safety Results of Combined Adenoviral VEGF-C and Lymph Node Transfer Treatment for Upper Extremity Lymphedema

Lymphedema is a common problem after breast cancer treatment. Lymfactin® is a prolymphangiogenic growth factor vector inducing the expression of human vascular endothelial growth factor C (VEGF-C). It promotes growth and repair of lymphatic vessels. Lymfactin® was combined with microvascular lymph n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of plastic, reconstructive & aesthetic surgery reconstructive & aesthetic surgery, 2022-11, Vol.75 (11), p.3938-3945
Hauptverfasser: Leppäpuska, Ida-Maria, Hartiala, Pauliina, Suominen, Sinikka, Suominen, Erkki, Kaartinen, Ilkka, Mäki, Maija, Seppänen, Marko, Kiiski, Juha, Viitanen, Tiina, Lahdenperä, Outi, Vuolanto, Antti, Alitalo, Kari, Saarikko, Anne M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!